PCDH19-Related Epilepsies

 

 Buy Article Permissions and Reprints

Abstract

Protocadherin-19 (PCDH19) is considered one of the most relevant genes related to epilepsy. To date, more than 150 mutations have been identified as causative for PCDH19-female epilepsy (also known as early infantile epileptic encephalopathy-9, EIEE9), which is characterized by early onset epilepsy, intellectual disabilities, and behavioral disturbances. More recently, mosaic-males (i.e., exhibiting the variants in less than 25% of their cells) have been described as affected by infant-onset epilepsy associated with intellectual disability, as well as compulsive or aggressive behavior and autistic features. Although little is known about the physiological role of PCDH19 protein and the pathogenic mechanisms that lead to EIEE9, many reports and clinical observation seem to suggest a relevant role of this protein in the development of cellular hyperexcitability. However, a genotype–phenotype correlation is difficult to establish. The main feature of EIEE9 consists in early onset of seizures, which generally occur in clusters lasting 1 to 5 minutes and repeating up to 10 times a day for several days. Seizures tend to present during febrile episodes, similarly to the first phases of Dravet syndrome and PCDH19 variants have been found in ∼25% of females who present with features of Dravet syndrome and testing negative for SCN1A variants. There is no “standardized” treatment for PCDH19-related epilepsy and most of the patients receiving a combination of several drugs. In this review, we focus on the latest researches on these aspects, with regard to protein expression, its known functions, and the mechanisms by which the protein acts. The clinical phenotypes related to PCDH19 mutations are also discussed.

Publication History

Received: 17 September 2020

Accepted: 24 February 2021

Article published online:
21 May 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

• References

• 1 Juberg RC, Hellman CD. A new familial form of convulsive disorder and mental retardation limited to females. J Pediatr 1971; 79 (05) 726-732
  CrossrefPubMedGoogle Scholar
• 2 Scheffer IE, Turner SJ, Dibbens LM. et al. Epilepsy and mental retardation limited to females: an under-recognized disorder. Brain 2008; 131 (Pt 4): 918-927
  CrossrefPubMedGoogle Scholar
• 3 Kolc KL, Sadleir LG, Scheffer IE. et al. A systematic review and meta-analysis of 271 PCDH19-variant individuals identifies psychiatric comorbidities, and association of seizure onset and disease severity. Mol Psychiatry 2019; 24 (02) 241-251
  CrossrefPubMedGoogle Scholar
• 4 Pavone P, Praticò AD, Falsaperla R. et al. Congenital generalized hypertrichosis: the skin as a clue to complex malformation syndromes. Ital J Pediatr 2015; 41: 55
  CrossrefPubMedGoogle Scholar
• 5 Pavone P, Briuglia S, Falsaperla R. et al. Wide spectrum of congenital anomalies including choanal atresia, malformed extremities, and brain and spinal malformations in a girl with a de novo 5.6-Mb deletion of 13q12.11-13q12.13. Am J Med Genet A 2014; 164A (07) 1734-1743
  CrossrefPubMedGoogle Scholar
• 6 Ruggieri M. Mosaic (segmental) neurofibromatosis type 1 (NF1) and type 2 (NF2): no longer neurofibromatosis type 5 (NF5). Am J Med Genet 2001; 101 (02) 178-180
  CrossrefPubMedGoogle Scholar
• 7 Ruggieri M, Polizzi A, Spalice A. et al. The natural history of spinal neurofibromatosis: a critical review of clinical and genetic features. Clin Genet 2015; 87 (05) 401-410
  CrossrefPubMedGoogle Scholar
• 8 Ruggieri M, Polizzi A. Segmental neurofibromatosis. J Neurosurg 2000; 93 (03) 530-532
  PubMedGoogle Scholar
• 9 Jamal SM, Basran RK, Newton S, Wang Z, Milunsky JM. Novel de novo PCDH19 mutations in three unrelated females with epilepsy female restricted mental retardation syndrome. Am J Med Genet A 2010; 152A (10) 2475-2481
  CrossrefPubMedGoogle Scholar
• 10 Marini C, Mei D, Parmeggiani L. et al. Protocadherin 19 mutations in girls with infantile-onset epilepsy. Neurology 2010; 75 (07) 646-653
  CrossrefPubMedGoogle Scholar
• 11 Praticò AD, Falsaperla R, Ruggieri M, Corsello G, Pavone P. Prognostic challenges of SCN1A genetic mutations: report on two children with mild features. J Pediatr Neurol 2016; 14: 82-88
  Article in Thieme ConnectPubMedGoogle Scholar
• 12 Leonardi E, Sartori S, Vecchi M. et al. Identification of four novel PCDH19 Mutations and prediction of their functional impact. Ann Hum Genet 2014; 78 (06) 389-398
  CrossrefPubMedGoogle Scholar
• 13 Ruggieri M, Iannetti P, Clementi M. et al. Neurofibromatosis type 1 and infantile spasms. Childs Nerv Syst 2009; 25 (02) 211-216
  CrossrefPubMedGoogle Scholar
• 14 Lionetti E, Leonardi S, Franzonello C, Mancardi M, Ruggieri M, Catassi C. Gluten psychosis: confirmation of a new clinical entity. Nutrients 2015; 7 (07) 5532-5539
  CrossrefPubMedGoogle Scholar
• 15 Ruggieri M, Polizzi A, Pavone L, Musumeci S. Thalamic syndrome in children with measles infection and selective, reversible thalamic involvement. Pediatrics 1998; 101 (1 Pt 1): 112-119
  CrossrefPubMedGoogle Scholar
• 16 Lionetti E, Francavilla R, Maiuri L. et al. Headache in pediatric patients with celiac disease and its prevalence as a diagnostic clue. J Pediatr Gastroenterol Nutr 2009; 49 (02) 202-207
  CrossrefPubMedGoogle Scholar
• 17 Smith L, Singhal N, El Achkar CM. et al. PCDH19-related epilepsy is associated with a broad neurodevelopmental spectrum. Epilepsia 2018; 59 (03) 679-689
  CrossrefPubMedGoogle Scholar
• 18 Vlaskamp DRM, Bassett AS, Sullivan JE. et al. Schizophrenia is a later-onset feature of PCDH19 girls clustering epilepsy. Epilepsia 2019; 60 (03) 429-440
  CrossrefPubMedGoogle Scholar
• 19 Depienne C, Bouteiller D, Keren B. et al. Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females. PLoS Genet 2009; 5 (02) e1000381
  CrossrefPubMedGoogle Scholar
• 20 Ruggieri M, Polizzi A, Marceca GP, Catanzaro S, Praticò AD, Di Rocco C. Introduction to phacomatoses (neurocutaneous disorders) in childhood. Childs Nerv Syst 2020; 36 (10) 2229-2268
  CrossrefPubMedGoogle Scholar
• 21 Dibbens LM, Tarpey PS, Hynes K. et al. X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment. Nat Genet 2008; 40 (06) 776-781
  CrossrefPubMedGoogle Scholar
• 22 Brancati F, Travaglini L, Zablocka D. et al; International JSRD Study Group. RPGRIP1L mutations are mainly associated with the cerebello-renal phenotype of Joubert syndrome-related disorders. Clin Genet 2008; 74 (02) 164-170
  CrossrefPubMedGoogle Scholar
• 23 Ruggieri M. Cutis tricolor: congenital hyper- and hypopigmented lesions in a background of normal skin with and without associated systemic features: further expansion of the phenotype. Eur J Pediatr 2000; 159 (10) 745-749
  CrossrefPubMedGoogle Scholar
• 24 Salpietro V, Polizzi A, Bertè LF. et al. Idiopathic intracranial hypertension: a unifying neuroendocrine hypothesis through the adrenal-brain axis. Neuroendocrinol Lett 2012; 33 (06) 569-573
  PubMedGoogle Scholar
• 25 O'Connor KC, Lopez-Amaya C, Gagne D. et al. Anti-myelin antibodies modulate clinical expression of childhood multiple sclerosis. J Neuroimmunol 2010; 223 (1-2): 92-99
  CrossrefPubMedGoogle Scholar
• 26 Pavone P, Praticò AD, Ruggieri M. et al. Acquired peripheral neuropathy: a report on 20 children. Int J Immunopathol Pharmacol 2012; 25 (02) 513-517
  CrossrefPubMedGoogle Scholar
• 27 Liu A, Yang X, Yang X. et al. Mosaicism and incomplete penetrance of PCDH19 mutations. J Med Genet 2019; 56 (02) 81-88
  CrossrefPubMedGoogle Scholar
• 28 Hynes K, Tarpey P, Dibbens LM. et al. Epilepsy and mental retardation limited to females with PCDH19 mutations can present de novo or in single generation families. J Med Genet 2010; 47 (03) 211-216
  CrossrefPubMedGoogle Scholar
• 29 Pederick DT, Homan CC, Jaehne EJ. et al. PCDH19 19 loss of function increases neuronal migration in vitro but is dispensable for brain development in mice. Sci Rep 2016; 6: 26765
  CrossrefPubMedGoogle Scholar
• 30 Pavone V, Signorelli SS, Praticò AD. et al. Total hemi-overgrowth in pigmentary mosaicism of the (hypomelanosis of) Ito type: eight case reports. Medicine (Baltimore) 2016; 95 (10) e2705
  CrossrefPubMedGoogle Scholar
• 31 Ruggieri M, Tigano G, Mazzone D, Tiné A, Pavone L. Involvement of the white matter in hypomelanosis of Ito (incontinentia pigmenti achromiens). Neurology 1996; 46 (02) 485-492
  CrossrefPubMedGoogle Scholar
• 32 Depienne C, LeGuern E. PCDH19-related infantile epileptic encephalopathy: an unusual X-linked inheritance disorder. Hum Mutat 2012; 33 (04) 627-634
  CrossrefPubMedGoogle Scholar
• 33 Sorge G, Ruggieri M, Polizzi A, Scuderi A, Di Pietro M. SHORT syndrome: a new case with probable autosomal dominant inheritance. Am J Med Genet 1996; 61 (02) 178-181
  CrossrefPubMedGoogle Scholar
• 34 van Harssel JJ, Weckhuysen S, van Kempen MJ. et al. Clinical and genetic aspects of PCDH19-related epilepsy syndromes and the possible role of PCDH19 mutations in males with autism spectrum disorders. Neurogenetics 2013; 14 (01) 23-34
  CrossrefPubMedGoogle Scholar
• 35 Terracciano A, Trivisano M, Cusmai R. et al. PCDH19-related epilepsy in two mosaic male patients. Epilepsia 2016; 57 (03) e51-e55
  CrossrefPubMedGoogle Scholar
• 36 Thiffault I, Farrow E, Smith L. et al. PCDH19-related epileptic encephalopathy in a male mosaic for a truncating variant. Am J Med Genet A 2016; 170 (06) 1585-1589
  CrossrefPubMedGoogle Scholar
• 37 Falsaperla R, Perciavalle V, Pavone P. et al. Unilateral eye blinking arising from the ictal ipsilateral occipital area. Clin EEG Neurosci 2016; 47 (03) 243-246
  CrossrefPubMedGoogle Scholar
• 38 Incorpora G, Pavone P, Castellano-Chiodo D, Praticò AD, Ruggieri M, Pavone L. Gelastic seizures due to hypothalamic hamartoma: rapid resolution after endoscopic tumor disconnection. Neurocase 2013; 19 (05) 458-461
  CrossrefPubMedGoogle Scholar
• 39 Pratico AD, Longo L, Mansueto S. et al. Off-label use of drugs and adverse drug reactions in pediatric units: a prospective, multicenter study. Curr Drug Saf 2018; 13 (03) 200-207
  CrossrefPubMedGoogle Scholar
• 40 Specchio N, Marini C, Terracciano A. et al. Spectrum of phenotypes in female patients with epilepsy due to protocadherin 19 mutations. Epilepsia 2011; 52 (07) 1251-1257
  CrossrefPubMedGoogle Scholar
• 41 Marini C, Darra F, Specchio N. et al. Focal seizures with affective symptoms are a major feature of PCDH19 gene-related epilepsy. Epilepsia 2012; 53 (12) 2111-2119
  CrossrefPubMedGoogle Scholar
• 42 Ruggieri M, McShane MA. Parental view of epilepsy in Angelman syndrome: a questionnaire study. Arch Dis Child 1998; 79 (05) 423-426
  CrossrefPubMedGoogle Scholar
• 43 Ruggieri M, Rizzo R, Pavone P, Baieli S, Sorge G, Happle R. Temporal triangular alopecia in association with mental retardation and epilepsy in a mother and daughter. Arch Dermatol 2000; 136 (03) 426-427
  CrossrefPubMedGoogle Scholar
• 44 Pavone P, Falsaperla R, Ruggieri M, Praticò AD, Pavone L. West syndrome treatment: new roads for an old syndrome. Front Neurol 2013; 4: 113
  CrossrefPubMedGoogle Scholar
• 45 Higurashi N, Nakamura M, Sugai M. et al. PCDH19-related female-limited epilepsy: further details regarding early clinical features and therapeutic efficacy. Epilepsy Res 2013; 106 (1-2): 191-199
  CrossrefPubMedGoogle Scholar
• 46 Ikeda H, Imai K, Ikeda H. et al. Characteristic phasic evolution of convulsive seizure in PCDH19-related epilepsy. Epileptic Disord 2016; 18 (01) 26-33
  CrossrefPubMedGoogle Scholar
• 47 Trivisano M, Pietrafusa N, Terracciano A. et al. Defining the electroclinical phenotype and outcome of PCDH19-related epilepsy: a multicenter study. Epilepsia 2018; 59 (12) 2260-2271
  CrossrefPubMedGoogle Scholar
• 48 Specchio N, Fusco L, Vigevano F. Acute-onset epilepsy triggered by fever mimicking FIRES (febrile infection-related epilepsy syndrome): the role of protocadherin 19 (PCDH19) gene mutation. Epilepsia 2011; 52 (11) e172-e175
  CrossrefPubMedGoogle Scholar
• 49 Lyons S, Marnane M, Reavey E, Williams N, Costello D. PCDH19-related epilepsy: a rare but recognisable clinical syndrome in females. Pract Neurol 2017; 17 (04) 314-317
  CrossrefPubMedGoogle Scholar
• 50 Ruggieri M, Gabriele AL, Polizzi A. et al. Natural history of neurofibromatosis type 2 with onset before the age of 1 year. Neurogenetics 2013; 14 (02) 89-98
  CrossrefPubMedGoogle Scholar
• 51 Kurian M, Korff CM, Ranza E. et al. Focal cortical malformations in children with early infantile epilepsy and PCDH19 mutations: case report. Dev Med Child Neurol 2018; 60 (01) 100-105
  CrossrefPubMedGoogle Scholar
• 52 Trevisano M, Specchio N. Focal cortical dysplasia in genetic epilepsy: new insights from PCDH19-related epilepsy. Dev Med Child Neurol 2018; 60: 6-12
  PubMedGoogle Scholar
• 53 Ruggieri M, Huson SM. The neurofibromatoses. An overview. Ital J Neurol Sci 1999; 20 (02) 89-108
  CrossrefPubMedGoogle Scholar
• 54 Perez D, Hsieh DT, Rohena L. Somatic mosaicism of PCDH19 in a male with early infantile epileptic encephalopathy and review of the literature. Am J Med Genet A 2017; 173 (06) 1625-1630
  CrossrefPubMedGoogle Scholar
• 55 de Lange IM, Rump P, Neuteboom RF. et al. Male patients affected by mosaic PCDH19 mutations: five new cases. Neurogenetics 2017; 18 (03) 147-153
  CrossrefPubMedGoogle Scholar
• 56 Tan Y, Hou M, Ma S. et al. Chinese cases of early infantile epileptic encephalopathy: a novel mutation in the PCDH19 gene was proved in a mosaic male-case report. . Med Genetics 2018; 19: 1-8
  PubMedGoogle Scholar
• 57 Salpietro V, Mankad K, Kinali M. et al. Pediatric idiopathic intracranial hypertension and the underlying endocrine-metabolic dysfunction: a pilot study. J Pediatr Endocrinol Metab 2014; 27 (1-2): 107-115
  CrossrefPubMedGoogle Scholar
• 58 Ruggieri M, Pavone V, De Luca D, Franzò A, Tiné A, Pavone L. Congenital bone malformations in patients with neurofibromatosis type 1 (Nf1). J Pediatr Orthop 1999; 19 (03) 301-305
  CrossrefPubMedGoogle Scholar
• 59 Camacho A, Simón R, Sanz R, Viñuela A, Martínez-Salio A, Mateos F. Cognitive and behavioral profile in females with epilepsy with PDCH19 mutation: two novel mutations and review of the literature. Epilepsy Behav 2012; 24 (01) 134-137
  CrossrefPubMedGoogle Scholar
• 60 Salpietro V, Polizzi A, Di Rosa G. et al. Adrenal disorders and the paediatric brain: pathophysiological considerations and clinical implications. Int J Endocrinol 2014; 2014: 282489
  CrossrefPubMedGoogle Scholar
• 61 Trivisano M, Lucchi C, Rustichelli C. et al. Reduced steroidogenesis in patients with PCDH19-female limited epilepsy. Epilepsia 2017; 58 (06) e91-e95
  CrossrefPubMedGoogle Scholar
• 62 Hayashi S, Inoue Y, Hattori S. et al. Loss of X-linked Protocadherin-19 differentially affects the behavior of heterozygous female and hemizygous male mice. Sci Rep 2017; 7 (01) 5801
  CrossrefPubMedGoogle Scholar
• 63 Gerosa L, Francolini M, Bassani S, Passafaro M. The role of protocadherin 19 (PCDH19) in neurodevelopment and in the pathophysiology of Early Infantile Epileptic Encepahlopathy-9 (EIEE9). Dev Neurobiol 2019; 79 (01) 75-84
  CrossrefPubMedGoogle Scholar
• 64 Ruggieri M, Praticò AD, Caltabiano R, Polizzi A. Early history of the different forms of neurofibromatosis from ancient Egypt to the British Empire and beyond: First descriptions, medical curiosities, misconceptions, landmarks, and the persons behind the syndromes. Am J Med Genet A 2018; 176 (03) 515-550
  CrossrefPubMedGoogle Scholar
• 65 Barbagallo M, Ruggieri M, Incorpora G. et al. Infantile spasms in the setting of Sturge-Weber syndrome. Childs Nerv Syst 2009; 25 (01) 111-118
  CrossrefPubMedGoogle Scholar
• 66 Ruggieri M, Praticò AD, Serra A. et al. Early history of neurofibromatosis type 2 and related forms: earliest descriptions of acoustic neuromas, medical curiosities, misconceptions, landmarks and the pioneers behind the eponyms. Childs Nerv Syst 2017; 33 (04) 549-560
  CrossrefPubMedGoogle Scholar
• 67 Ruggieri M, Praticò AD, Scuderi A, Sorge G, Polizzi A. The multiple faces of artwork diagnoses. Lancet Neurol 2017; 16 (06) 417-418
  CrossrefPubMedGoogle Scholar
• 68 Lotte J, Bast T, Borusiak P. et al. Effectiveness of antiepileptic therapy in patients with PCDH19 mutations. Seizure 2016; 35: 106-110
  CrossrefPubMedGoogle Scholar
• 69 Praticò AD, Ruggieri M, Falsaperla R, Pavone P. A probable topiramate-induced limbs paraesthesia and rigid fingers flexion. Curr Drug Saf 2018; 13 (02) 131-136
  CrossrefPubMedGoogle Scholar
• 70 Praticò AD, Pavone P, Scuderi MG. et al. Symptomatic hypocalcemia in an epileptic child treated with valproic acid plus lamotrigine: a case report. Cases J 2009; 2: 7394
  PubMedGoogle Scholar
• 71 Falsaperla R, D'Angelo G, Praticò AD. et al. Ketogenic diet for infants with epilepsy: a literature review. Epilepsy Behav 2020; 112: 107361
  CrossrefPubMedGoogle Scholar
• 72 Trivisano M, Specchio N, Vigevano F. Extending the use of stiripentol to other epileptic syndromes: a case of PCDH19-related epilepsy. Eur J Paediatr Neurol 2015; 19 (02) 248-250
  CrossrefPubMedGoogle Scholar
• 73 Tan C, Shard C, Ranieri E. et al. Mutations of protocadherin 19 in female epilepsy (PCDH19-FE) lead to allopregnanolone deficiency. Hum Mol Genet 2015; 24 (18) 5250-5259
  CrossrefPubMedGoogle Scholar
• 74 Higurashi N, Takahashi Y, Kashimada A. et al. Immediate suppression of seizure clusters by corticosteroids in PCDH19 female epilepsy. Seizure 2015; 27: 1-5
  CrossrefPubMedGoogle Scholar
• 75 Pavone P, Falsaperla R, Ruggieri M. et al. Clinical course of N-methyl-D-aspartate receptor encephalitis and the effectiveness of cyclophosphamide treatment. J Pediatr Neurol 2017; 15: 84-49
  Article in Thieme ConnectPubMedGoogle Scholar
• 76 US National Library of Medicine. Clinicaltrials.gov. https://clinicaltrials.gov/ct2/home//NCT03865732?cond=PCDH19&rank=1 . Accessed March 15, 2021
  PubMedGoogle Scholar